Eczema and dermatitis

Allergy and Clinical Immunology International

Volumn 17, Issue 1, 2005, Pages 19-25

  Ring, Johannes ^a   Darsow, Ulf ^a   Jacob, Thilo ^a   Behrendt, Heidrun ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Atopy; Contact dermatitis; Dermatitis; Eczema; Terminology

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ALLERGEN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BALSAM PERU; BENZOCAINE; CALCINEURIN INHIBITOR; CLIOQUINOL; COBALT CHLORIDE; CORTICOSTEROID; CRYSTAL VIOLET; DICHROMATE POTASSIUM; DISULFIRAM; FORMALDEHYDE; FRAGRANCE; ICHTHAMMOL; IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; LANOLIN ALCOHOL; NEOMYCIN; NICKEL SULFATE; PHENYLENEDIAMINE DERIVATIVE; ROSIN; TRICLOSAN; TUBERCULIN;

ARTICLE; ATOPIC DERMATITIS; CLINICAL FEATURE; CONTACT DERMATITIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; HUMAN; PATHOPHYSIOLOGY; PHOTOTHERAPY; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SOCIAL STATUS; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

EID: 15344339938     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.17.1.19     Document Type: Article

References (71)

1. Ackermann AB, Ragaz A. A plea to expunge the word eczema from the lexicon of dermatology and dermatopathology. Am J Dermatopathol 1982; 4: 315-326
2. Akdis CA, Akdis M, Trautmann A, Blaser K. Immune regulation in atopic dermatitis. Curr Opin Immunol 2000; 12:641-646
3. + Th2 cells. Eur J lmmunol 2000; 30:3533-3541
4. Andersen KE, Benezra C, Burrows D, Camarasa J, Dooms-Goossens A, Ducombs G, Frosch P, Lachapelle JM, Lahti A, Menné T; The European environmental and contact dermatitis research group. Contact dermatitis: A review. Contact Dermatitis 1987; 16:55-78
5. Bieber T, de la Salle C, Wollenberg A, Hakimi J, Chizzonite R, Ring J. Constitutive expression of the high affinity receptor for IgE (FcεRI) on human Langerhans cells. J Exp Med 1992; 175:1285-1290
6. Bieber T. FcεRI on human Langerhans cells: A receptor in seach of new functions. Immunol Today 1994; 15:52-53
7. Bruijnzeel-Koomen C, van Wichen D, Spry C, Venge P, Bruijnzeel P. Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br J Dermatol 1988; 118:229-238
8. Bruijnzeel-Koomen C, van Wichen DF, Toonstra J, Berrens L, Bruijnzeel PLB. The presence of IgE molecules on epidermal Langerhans cells in patients with atopic dermatitis. Arch Dermatol Res 1986; 278:199-205
9. Cavani A, Albanesi C, Traidl C, Sebastiani S, Girolomoni G. Effector and regulatory T cells in allergic contact dermatitis. Trends Immunol 2001; 22:118-120
10. Coca A, Cooke RA. On the classification of the phenomenon of hypersensitiveness. J Immunol 1923; 8:163-182
11. Cooper KD, Stevens SR. T cells in atopic dermatitis. J Am Acad Dermatol 2001; 45:510-512
12. Darsow U, Behrendt H, Ring J. Gramineae pollen as trigger factors of atopic eczema: Evaluation of diagnostic measures using the atopy patch test. Br J Dermatol 1997; 137:201-207
13. Darsow U, Ring J. Airborne and dietary allergens in atopic eczema:a comprehensive review of diagnostic tests. Clin Exp Dermatol 2000; 25:544-551
14. Darsow U, Vieluf D, Ring J. Atopy patch test with different vehicles and allergen concentrations: An approach to standardization. J Allergy Clin Immunol 1995; 95:677-684
15. Darsow U, Vieluf D, Ring J. The atopy patch test: An increased rate of reactivity in patients who have an air-exposed pattern of atopic eczema. Br J Dermatol 1996; 135:182-186
16. De Groot AC. Patch testing. Amsterdam: Elsevier, 1994
17. Enders F, Przybilla B, Ring J. Atopy and contact allergy. In J Ring, B Przybilla (Eds) New Trends in Allergy III. Berlin: Springer, p. 409-416
18. Epstein WL, Kligman A. Some factors affecting the reaction of allergic contact dermatitis. J Invest Dermatol 1959; 33:231-243
19. European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: The SCORAD index. Dermatology 1993; 186:23-31
20. Fisher AA. Contact Dermatitis. 3rd edition. Philadelphia: Lea & Febiger, 1986, p. 686-691
21. Gieler U, Kupfer J, Niemeier V, Brosig B, Stangier U. Atopic eczema prevention programs: A new therapeutic concept for secondary prevention. Dermatol Psychosom 2000; 1:138-147
22. Grewe M, Gyufko K, Schöpf E, Krutmann J. Lesional expression of interferon-gamma in atopic eczema. Lancet 1994; 1:25-26
23. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980; 114:146-148
24. Johansson SGO, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B; EAACI (the European Academy of Allergology and Cinical Immunology) nomenclature task force. A revised nomenclature for allergy: An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-824
25. Jones HE, Inouye JC, McGerity JL, Lewis CW. Atopic disease and serum immunoglobulin E. Br J Dermatol 1975; 92:17-25
26. Kapp A. Atopic Dermatitis: The skin manifestation of atopy. Clin Exp Allergy 1995; 25:210-219
27. Kunz B, Ring J. Clinic diagnostic features of atopic eczema. In J Harper, A Oranje N Prose (Eds) Pediatric Dermatology, vol. 2. Oxford: Blackwell, 1999, p. 199-214
28. Langeland T, Braathen L, Borch M. Studies of atopic patch tests. Acta Derm Venereol Suppl (Stockh) 1989; 144:105-109
29. Lepoittevin JP, Benezra C, Sigman CC, Baheri D, Fraginals R, Maibach HI. Molecular aspects of allergic contact dermatitis. In RJG Rycroft, T Menné, P Frosch (Eds) Textbook of contact dermatitits Berlin: Springer, 1995, p. 105-119
30. Leung DY. Atopic dermatitis and the immune system: The role of superantigens and bacteria. J Am Acad Dermatol 2001; 45:13-16
31. Macher E, Chase MW. Studies on the sensitization of animals with simple chemical compounds. XI. The fate of labled picryl chloride and dinitro chlorobenzene after sensitizing injections. J Exp Med 1969; 129:81-86
32. Maeda K, Yamamoto K, Tanaka Y, Anan S, Yoshida H. House dust mite (HDM) antigen in naturally occurring lesions of atopic dermatitis (AD): The relationship between HDM antigen in the skin and HDM antigen-specific IgE antibody. J Derm Science 1992; 3:73-77
33. Maibach HI. The ESS, excited-skin syndrome (alias the "angryback"). In J Ring, G Burg (Eds) New Trends in Allergy. Berlin: Springer, 1981, p. 206-216
34. Maurer D, Ebner C, Reininger B, Fiebiger E, Kraft D, Kinet JP, Stingl G. The high affinity IgE receptor mediates IgE-dependent allergen presentation. J Immunol 1995; 154:6285-6290
35. Mitchell E, Chapman M, Pope F, Crow J, Jouhal S, Platts-Mills T. Basophils in allergen-induced patch test sites in atopic dermatitis. Lancet 1982; 1:127-130
36. Mitchell JC. The angry back syndrome: Eczema creates eczema. Contact Derm 1975; 1:193-194
37. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J lmmunol 1986; 136:2348-2357
38. Parish LC, Crissey JT. The Dermatology and Syphilology of the nineteenth century. New York: Praeger, 1979
39. Platts-Mills T, Mitchell E, Rowntree S, Chapman M, Wilkins S. The role of dust mite allergens in atopic dermatitis. Clin Exp Dermatol 1983; 8:233-247
40. Przybilla B, Ring J. Food allergy and atopic eczema. Semin Dermatol 1990; 9:220-225
41. Przybilla B. Stigmata of the atopic constitution. In T Ruzicka, J Ring, B Przybilla (Eds) Handbook of atopic eczema. Berlin: Springer, 1991, p. 31-45
42. Rajka G. Essential aspects of atopic dermatitis. Berlin: Springer, 1989
43. Ramb-Lindhauer CH, Feldmann A, Rotte M, Neumann CH. Characterization of grass pollen reactive T cell lines derived from lesional atopic skin. Arch Dermatol Res 1991; 283:71-76
44. Reitamo S, Visa K, Kaehoenen K, Käykhö A, Lauerna I, Stubb S, Salo OP. Patch test reactions to inhalant allergens in atopic dermatitis. Acta Derm Venereol (Stockh) 1989; 144:119-121
45. Renz H, Jujo K, Bradley K, Domenico J, Gelfand EW, Leung DY. Enhanced IL-4 production and IL-4 receptor expression in atopic dermatitis and their modulation by interferon-gamma. J Invest Dermatol 1992; 99:403-408
46. Rietschel RL, Fouler JF. Fisher's contact dermatitis. 5th ed. Philadelphia: Lippincott-Williams, 2001
47. Ring J, Krämer U, Schäfer T, Behrendt H. Why are allergies increasing? Curr Opin Immunol 2001; 13:701-708
48. Ring J, Bieber T, Vieluf D, Kunz B, Przybilla B. Atopic eczema, Langerhans cells and allergy. Int Arch Allergy Appl Immunol 1991; 94:194-201
49. Ring J, Brockow K, Abeck D. The therapeutic concept of "patient management" in atopic eczema. Allergy 1996; 51:206-215
50. Ring J, Kunz B, Bieber T, Vieluf D, Przybilla B. The "atopy patch test" with aeroallergens in atopic eczema (abstr). J Allergy Clin Immunol 1989; 82:195
51. Ring J. Allergy in Practice, Berlin, New York: Springer, 2005 (in press)
52. Ring J. Atopy: Condition, disease, or syndrome? In T Ruzicka, J Ring, B Przybilla (Eds) Handbook of atopic eczema. Berlin: Springer, 1991, p. 3-8
53. Ring J. Changing Aspects of the Eczema Terminology: Classic Versus Atopic Eczema. Zeitschrift für Hautkrankheiten 1996; 71:752-756
54. Rycroft RJG, Menné T, Frosch P (Eds). Textbook of Contact Dermatitis. Berlin: Springer, 1995
55. Ruzicka T, Ring J, Przybilla B (Eds). Handbook of atopic eczema. Berlin: Springer, 1991
56. Sager N, Feldmann A, Schilling G, Kreitsch P, Neumann C. House dust mite-specific T cells in the skin of subjects with atopic dermatitis: Frequency and lymphokine profile in the allergen patch test. J Allergy Clin Immunol 1992; 89:801-810
57. Schäfer T, Krämer U, Vieluf D, Abeck D, Behrendt H, Ring J. The excess of atopic exzema in East Germany is related to the intrinsic type. Br J Dermatol 2000; 143:992-998
58. Seidenari S, Manzini M, Danese P. Patch testing with pollens of Gramineae in patients with atopic dermatitis and mucosal atopy. Contact Dermatitis 1992; 27:125-6
59. Stingl G, Wolff-Schreiner EC, Pichler W, Gschnait F, Knapp W, Wolff K. Epidermal Langerhans cells bear Fc and C3 receptors. Nature 1977; 268:245
60. Taieb A. Hypthesis: From epidermal barrier dysfunction to atopic disorders. Contact Dermatitis 1999; 41:177-180
61. Tan B, Weald D, Strickland I, Friedmann P. Double-blind controlled trial of effect of housedust-mite allergen avoidance on atopic dermatitis. Lancet 1996; 347:15-18
62. Tanaka Y, Anan S, Yoshida H. Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J Derm Science 1990; 1:361-368
63. Valenta R, Seiberler S, Natter S, Mahler V, Mossabeb R, Ring J, Stingl G. Allergy: A pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol 2000; 105:432-437
64. van Reijsen FC, Bruynzeel-Koomen CAFM, Kalthoff FS, Maggi E, Romagnani S, Westland JKT, Mudde GC. Skin-derived aeroallergen-specific T-cell clones of Th2 phenotype in patiens with atopic dermatitis. J Allergy Clin Immunol 1992; 90:184-192
65. Veien NK, Kaaber K. Nickel, cobalt and chromium sensitivity in patients with pompholyx (dyshidrotic eczema). Contact Dermatitis 1979; 5: 371-374
66. Vercelli D, Jabara H, Lauener R, Geha R. IL-4 inhibits the synthesis of INF-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures. J Immunol 1990; 144:570-573
67. Vieluf D, Kunz B, Bieber T, Przybilla B, Ring J. "Atopy Patch Test" with aeroallergens in patients with atopic eczema. Allergo J 1993; 2:9-12
68. Wistokat-Wülfing A, Schmidt P, Darsow U, Ring J, Kapp A, Werfel T. Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy 1999; 29:513-521
69. Wollenberg A, Wen S, Bieber T. Phenotyping of epidermal dendritic cells: Clinical applications of a flow cytometric micromethod. Cytometry 1999; 37:147-155
70. Wüthrich B (ed). The atopy syndrome in the third millennium. Basel: Karger, 1999
71. Wüthrich B. Neurodermitis atopica sive constitutionalis. Ein pathogenetisches Modell aus der Sicht des Allergologen. Akt Dermatol 1983; 9:1-7